Editor`s Picks

Reports Q4 2020 results on Thursday, Jan. 21, after the market close Revenue Expectation: $20.64 billion EPS Expectation: $1.81 When International Business Machines (NYSE:IBM) reports fourth-quarter...

Saying that Moderna (NASDAQ:MRNA) was the best performing COVID-19 vaccine stock in the past year would be a laughable understatement. Shares of  AstraZeneca (NASDAQ:AZN) gained 0.25% for the...

Fidelity Investments, whose history goes back to the early 1940s, has long been associated with mutual funds. However, in recent years, the group has also increased its exchange-traded funds...

In the coming days, Wall Street’s fourth quarter earnings season will kick into high gear. Investors are bracing for another uncertain reporting season amid the impact of the ongoing coronavirus...

Is the selloff in gold over?I’m inclined to say your guess is as good as mine—although the evidence suggests that this should not be a question, especially now that significant additional...

As President-elect Joe Biden gets ready to take the oath of office later today in Washington DC, Wall Street wonders which stocks could continue to do well in future quarters. We recently discussed...

When 23 elderly Norwegians died recently, after receiving the Pfizer (NYSE:PFE) COVID-19 vaccine, China's Communist Party tabloid The Global Times posited that the fatalities were receiving little...

The new year is off to an excellent start for the cannabis sector, and among the big winners is Aphria (NASDAQ:APHA) (TSX:APHA).Last week, the Canadian-based marijuana grower recorded $160.5...